Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reverse transcription in HIV refers to the process by which the virus converts its single-stranded RNA genome into double-stranded DNA. This step is essential for viral replication and integration into the host genome. The enzyme responsible for this process is called reverse transcriptase (RT), a hallmark of all retroviruses, including HIV-1. Inhibiting reverse transcription blocks production of proviral DNA, preventing establishment or maintenance of chronic infection. This makes it one of the primary intervention points in current combination therapies against HIV/AIDS.
Inhibition of reverse transcriptase activity, preventing viral DNA synthesis and integration into the host genome.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reverse transcription (HIV).